financetom
Business
financetom
/
Business
/
Market Chatter: Citgo Petroleum Bidders Down to CVR Energy, Creditors Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Citgo Petroleum Bidders Down to CVR Energy, Creditors Group
Aug 2, 2024 12:25 PM

02:48 PM EDT, 08/02/2024 (MT Newswires) -- The list of bidders for Houston-based oil refiner Citgo Petroleum has narrowed down to CVR Energy ( CVI ) and a group of creditors that includes miner Gold Reserve, Reuters reported Friday, citing three people familiar with the matter.

CVR Energy ( CVI ), which is controlled by activist investor Carl Icahn, has made an all-cash bid of about $8 billion, according to people with knowledge of the auction, Reuters reported.

That compares with the $9 billion in combined cash and claims against Venezuela being offered by the investment group, Reuters reported, citing two of the people familiar with the matter.

Both offers fall short of the $21.3 billion creditors are looking to recover from the auction of the business and are also below Citgo's market valuation of between $11 billion and $13 billion, Reuters reported.

A winning bid must be selected by Aug. 22 and approved by Oct. 15, Reuters reported.

A court ordered the sale of PDV Holding, which owns Citgo, as compensation for the country's past expropriations and debt defaults. Despite being owned by Venezuela, Citgo is no longer tied to the country after it severed ties with its ultimate parent PDVSA and began operating under a US license, according to the report.

CVR Energy ( CVI ), Gold Reserve, and Citgo did not immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 25.90, Change: -1.65, Percent Change: -5.97

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Check Point Software's Q2 revenue rises 6%, beats expectations
Check Point Software's Q2 revenue rises 6%, beats expectations
Jul 30, 2025
Overview * Check Point Q2 revenue rises 6% yr/yr, beating analyst expectations, per LSEG data * Adjusted EPS for Q2 increases 9%, exceeding analyst estimates, per LSEG data * Co repurchased about 1.5 mln shares for $325 mln during the second quarter of 2025 Outlook * Company sees strong indicators for Q3 2025 * Check Point anticipates healthy pipeline for...
GSK Q2 Core Earnings, Revenue Rise; Updates 2025 Guidance
GSK Q2 Core Earnings, Revenue Rise; Updates 2025 Guidance
Jul 30, 2025
05:01 AM EDT, 07/30/2025 (MT Newswires) -- GSK (GSK) reported Q2 core earnings Wednesday of 46.5 pence ($0.62) per diluted share, up from 43.4 pence a year earlier. Analysts polled by FactSet expected $0.59. Revenue for the quarter ended June 30 was 7.99 billion pounds, up from 7.88 billion pounds a year earlier. Analysts surveyed by FactSet expected 10.37 billion...
Madrigal and CSPC Pharmaceutical sign up to $2 billion licensing deal
Madrigal and CSPC Pharmaceutical sign up to $2 billion licensing deal
Jul 30, 2025
July 30 (Reuters) - Madrigal Pharmaceuticals ( MDGL ) said on Wednesday it has entered a global license agreement for up to $2 billion with CSPC Pharmaceutical ( CHJTF ) to develop an oral GLP-1 drug for a type of liver disease. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved